Sarah A Milgrom
Overview
Explore the profile of Sarah A Milgrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoppe B, Milgrom S, Renfro L, Wu Y, Schwartz C, Constine L, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39745710
No abstract available.
2.
Milgrom S, Lo A
Semin Radiat Oncol
. 2024 Dec;
35(1):47-56.
PMID: 39672642
Hematologic cancers in pediatric, adolescent, and young adult populations include a diverse spectrum of malignancies. The cornerstone of treatment is multiagent chemotherapy. While radiation therapy (RT) is highly effective and...
3.
Casey D, Murphy E, Shen C, Milgrom S, Larrier N, Bradley J, et al.
Pract Radiat Oncol
. 2024 Oct;
PMID: 39447866
Purpose: Despite the urgent need for improved outcomes in patients with metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS), it is unknown how to best approach metastatic-site radiation therapy for these...
4.
Saifi O, Pinnix C, Ballas L, Kelsey C, Milgrom S, Terezakis S, et al.
Lancet Haematol
. 2024 Oct;
11(12):e951-e958.
PMID: 39362223
Contemporary lymphoma radiation target volumes that rely on post-systemic therapy imaging do not have standardised nomenclature. A forum of radiation oncology lymphoma leaders from the National Clinical Trials Network groups...
5.
Brooks T, Gao D, Dorris K, Boone K, Mirsky D, Staulcup S, et al.
J Neurosurg Pediatr
. 2024 Sep;
34(6):642-648.
PMID: 39332032
Objective: In a cohort of patients who were treated with resection and adjuvant radiotherapy (RT) for adamantinomatous craniopharyngioma (ACP), the authors aimed to determine whether gross tumor volume (GTV) at...
6.
Kent A, Gil K, Jones M, Linden B, Purev E, Haverkos B, et al.
Transplant Cell Ther
. 2024 Aug;
PMID: 39154914
Despite the concurrent use of haploidentical cord (HCT) and dual cord (DCT) stem cell transplant approaches for over a decade, there have been few comparisons of their outcomes. Our objective...
7.
Lo A, Parikh R, Kamdar M, Milgrom S
Int J Radiat Oncol Biol Phys
. 2024 Aug;
120(1):1-9.
PMID: 39147428
No abstract available.
8.
Milgrom S, Dandapani S, Wong J, Kalapurakal J, Smith K, Han C, et al.
Pediatr Blood Cancer
. 2024 Aug;
71(11):e31185.
PMID: 39118225
Historically, total body irradiation (TBI) has been delivered using static, parallel opposed photon beams (2D-TBI). Recently, centers have increasingly used intensity-modulated radiation therapy (IMRT) techniques for TBI. Relative to 2D-TBI,...
9.
Heneghan M, Belsky J, Milgrom S, Forlenza C
Semin Hematol
. 2024 Jun;
61(4):245-252.
PMID: 38851951
Hodgkin lymphoma (HL) occurs throughout the lifespan but is one of the most common cancers in adolescents and young adults (AYA; 15-39 years). HL has become a highly curable disease...
10.
Kahn J, Mauz-Korholz C, Hernandez T, Milgrom S, Castellino S
Am Soc Clin Oncol Educ Book
. 2024 May;
44(3):e432420.
PMID: 38788179
Hodgkin lymphoma (HL) is a treatable cancer with an incidence peak in adolescent and young adult years. Treatment strategies have been developed to balance the intensity of therapy needed to...